Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis
- PMID: 30459172
- PMCID: PMC6276978
- DOI: 10.9778/cmajo.20180063
Patterns of borrowing to finance out-of-pocket prescription drug costs in Canada: a descriptive analysis
Abstract
Background: Out-of-pocket drug costs lead many Canadians to engage in cost-related nonadherence to prescription medications, but our understanding of other consequences such as borrowing money remains incomplete. In this descriptive study, we sought to quantify the frequency of borrowing to pay for prescription drugs in Canada and characteristics of Canadians who borrowed money for this purpose.
Methods: In partnership with Statistics Canada, we designed and administered a cross-sectional rapid-response module in the Canadian Community Health Survey administered by telephone to Canadians aged 12 years or more between January and June 2016. We restricted our analyses to participants who responded to the question regarding borrowing money to pay for prescription drugs and used logistic regression to identify characteristics associated with borrowing.
Results: A total of 28 091 Canadians responded to the survey (overall response rate 61.8%). The weighted proportion of respondents who reported having borrowed money to pay for prescription drugs in the previous year was 2.5% (95% confidence interval 2.2%-2.8%), an estimated 731 000 Canadians. The odds of borrowing were higher among younger adults, people in poor health and people lacking prescription drug insurance. Other factors associated with increased adjusted odds of borrowing were having 2 or more chronic conditions, low household income and higher out-of-pocket prescription drug costs.
Interpretation: Many Canadians reported borrowing money to pay for out-of-pocket prescription drug costs, and borrowing was more prevalent among already vulnerable groups that also report other compensatory behaviours to address challenges in paying for prescription drugs. Future research should investigate policy responses intended to increase equity in access to prescription drugs.
Copyright 2018, Joule Inc. or its licensors.
Conflict of interest statement
Competing interests: Michael Law has consulted for Health Canada and has acted as an expert witness for the Attorney General of Canada. Anne Holbrook is a therapeutics expert and drug policy consultant for the Ontario public drug programs, the Canadian Agency for Drugs and Technologies in Health and Hamilton hospitals. No other competing interests were declared.
Figures

Similar articles
-
The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.CMAJ Open. 2018 Feb 5;6(1):E63-E70. doi: 10.9778/cmajo.20180008. CMAJ Open. 2018. PMID: 29440236 Free PMC article.
-
A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health.Clin Ther. 2006 Aug;28(8):1217-1224. doi: 10.1016/j.clinthera.2006.07.009. Clin Ther. 2006. PMID: 16982299
-
Cost-related nonadherence to prescribed medicines among older Canadians in 2014: a cross-sectional analysis of a telephone survey.CMAJ Open. 2017 Jan 17;5(1):E40-E44. doi: 10.9778/cmajo.20160126. eCollection 2017 Jan-Mar. CMAJ Open. 2017. PMID: 28401117 Free PMC article.
-
Cost-related nonadherence to prescription medications in Canada: a scoping review.Patient Prefer Adherence. 2018 Sep 6;12:1699-1715. doi: 10.2147/PPA.S170417. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 30233150 Free PMC article.
-
Increasing Drug Costs: Are we getting good value?2006 Jul. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutics Initiative; 1994–. Letter 59. 2006 Jul. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutics Initiative; 1994–. Letter 59. PMID: 38620473 Free Books & Documents. Review.
Cited by
-
Demographic characteristics and cost of treatment among oncology patients in a publicly funded system, the Ontario Trillium Drug Program: a retrospective cohort study.CMAJ Open. 2019 Aug 20;7(3):E516-E523. doi: 10.9778/cmajo.20190011. Print 2019 Jul-Sep. CMAJ Open. 2019. PMID: 31431484 Free PMC article.
-
The relationship between patients' income and education and their access to pharmacological chronic pain management: A scoping review.Can J Pain. 2022 Sep 1;6(1):142-170. doi: 10.1080/24740527.2022.2104699. eCollection 2022. Can J Pain. 2022. PMID: 36092247 Free PMC article.
-
Effect of free medicine distribution on ability to make ends meet: post hoc quantitative subgroup analysis and qualitative thematic analysis.BMJ Open. 2022 Dec 22;12(12):e061726. doi: 10.1136/bmjopen-2022-061726. BMJ Open. 2022. PMID: 36549740 Free PMC article.
References
-
- National health expenditure trends, 1975 to 2016. Ottawa: Canadian Institute for Health Information; 2016.
-
- Hennessy D, Sanmartin C, Ronksley P, et al. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease. Health Rep. 2016;27:3–8. - PubMed
LinkOut - more resources
Full Text Sources